5 Results for: created: (01/2018 to 01/2018)

People

  1. Yu
    Yu
  2. Kris
    Kris
  3. Riely
    Riely
  4. Ahn
    Ahn
  5. Arbour
    Arbour
  6. Beal
    Beal
  7. Daras
    Daras
  8. Hayes
    Hayes
  9. Ni
    Ni
  10. Rodriguez
    Rodriguez

Groups

  1. Department of Medicine (5)
  2. Solid Tumor Oncology Division (5)
  3. Thoracic Oncology (5)
  4. Biostatistics Service (1)
  5. Epidemiology and Biostatistics (1)
  6. Multidisciplinary Brain Metastasis Program (1)
  7. Neuroradiology Service (1)
  8. Nursing (1)
  9. Radiology, Department of (1)
  10. Weinberg Fellows (1)
  1. "Helena Yu"
Formats
  1. Meeting Abstract (3)
  2. Journal Article (2)
Groups
  1. Department of Medicine (5)
  2. Solid Tumor Oncology Division (5)
  3. Thoracic Oncology (5)
  4. Biostatistics Service (1)
  5. Epidemiology and Biostatistics (1)
  6. Multidisciplinary Brain Metastasis Program (1)

More Groups

People
  1. Helena Yu (5)
  2. Gregory Riely (2)
  3. Mark Kris (2)
  4. Ai Ni (1)
  5. Christopher Rodriguez (1)
  6. Kathryn Arbour (1)

More People

Years
  1. 2018 (1)
  2. 2017 (4)
Publications
  1. Journal of Thoracic Oncology (3)
  2. Cancer (1)
  3. Clinical Cancer Research (1)
Publishers
  1. Elsevier Inc. (3)
  2. American Association for Cancer Research (1)
  3. Wiley Blackwell (1)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Twice weekly pulse and daily continuous-dose erlotinib as initial treatment for patients with epidermal growth factor receptor–mutant lung cancers and brain metastases
    Journal Article

    Arbour, K. C.; Kris, M. G.; Riely, G. J.; Ni, A.; Beal, K.; Daras, M.; Hayes, S. A.; Young, R. J.; Rodriguez, C. R.; Ahn, L.; more...
    Cancer (2018)

    Fulltext@MSK | Save
  • Clinical activity of osimertinib in EGFR mutation positive non-small cell lung cancer (NSCLC) patients (pts) previously treated with rociletinib
    Meeting Abstract

    Gadgeel, S.; Chen, W.; Piotrowska, Z.; Goldman, J. W.; Wakelee, H.; Camidge, D. R.; Varga, A.; Yu, H.; Papadimitrakopoulou, V.; Nea, J.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Phase 1 study of ramucirumab or necitumumab in combination with osimertinib (AZD9291) in advanced T790M-positive EGFR-mutant NSCLC
    Meeting Abstract

    Planchard, D.; Kris, M.; Besse, B.; Hozak, R.; He, S.; Gan, F.; Wolff, K.; Chao, B.; Yu, H.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • A highly sensitive next-generation sequencing platform for detection of NSCLC EGFR T790M mutation in urine and plasma
    Meeting Abstract

    Wakelee, H.; Melnikova, V.; Karlovich, C.; Gadgeel, S.; Reckamp, K.; Goldman, J. W.; Camidge, D. R.; Pérol, M.; Ou, S. H.; Liu, S.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • A phase I, dose escalation study of oral ASP8273 in patients with non–small cell lung cancers with epidermal growth factor receptor mutations
    Journal Article

    Yu, H. A.; Spira, A.; Horn, L.; Weiss, J.; West, H.; Giaccone, G.; Evans, T.; Kelly, R. J.; Desai, B.; Krivoshik, A.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save